BioSerenity
Founded Year
2014Stage
Series C | AliveTotal Raised
$94.22MAbout BioSerenity
BioSerenity develops wearable medical devices and digital point-of-care solutions, as well as electronic patient-reported outcome (ePRO), internet of things and cloud technologies.
BioSerenity Headquarter Location
Institut du Cerveau et de la Moelle Epinière 47, boulevard de l'hôpital
Paris, 75013,
France
+33(0)1 47 27 52 63
Research containing BioSerenity
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BioSerenity in 1 CB Insights research brief, most recently on Jul 1, 2020.
Expert Collections containing BioSerenity
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BioSerenity is included in 9 Expert Collections, including Wearable Computing.
Wearable Computing
387 items
Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.
Value-Based Care & Population Health
866 items
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Sleep Health & Wellness
800 items
These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.
Medical Devices
11,170 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
3,694 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Smart Home & Consumer Electronics
1,086 items
This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.
BioSerenity Patents
BioSerenity has filed 19 patents.
The 3 most popular patent topics include:
- Electroencephalography
- Electronic circuits
- Electrophysiology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/10/2017 | 1/26/2021 | Electronic circuit simulators, Electronic circuits, Electronic circuit verification, Electronic design automation, Electricity | Grant |
Application Date | 11/10/2017 |
|---|---|
Grant Date | 1/26/2021 |
Title | |
Related Topics | Electronic circuit simulators, Electronic circuits, Electronic circuit verification, Electronic design automation, Electricity |
Status | Grant |
Latest BioSerenity News
Apr 5, 2022
Epi USA, Empatica Inc., Medpage Ltd, Hipass Design LLC, American Medical ID, Sleep-Safe, Inspyre, Neurava, Bioserenity, MC10, Brain Sentinel, SeizAlarm, Smart Monitor, among others, are the key players in the portable seizure monitoring devices market. April 05, 2022 09:05 ET Mumbai, INDIA Brooklyn, New York, April 05, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Portable Seizure Monitoring Devices Market is projected to grow at a CAGR value of 4.4% from 2022 to 2027. The rising incidence and prevalence of seizures, increased desire for mobile healthcare and wearable, growing preference for constant monitoring, and rise in awareness of neurodegenerative diseases, especially epileptic seizures, are all factors driving market expansion during the forecast period. Key Market Insights As per the product type outlook, the wearable watches & bracelets segment is expected to grow the fastest in the market from 2022 to 2027. The android devices segment is expected to be the largest segment in the market from 2022 to 2027 as per the type of connectivity segmentation The ambulatory surgery centres & clinics segment is expected to be the largest segment in the market from 2022 to 2027 as per the end-user segmentation The North America (the United States, Canada, and Mexico) region, will have a dominant share in the Global Portable Seizure Monitoring Devices market from 2022 to 2027 Epi USA, Empatica Inc., Medpage Ltd, Hipass Design LLC, American Medical ID, Sleep-Safe, Inspyre, Neurava, Bioserenity, MC10, Brain Sentinel, SeizAlarm, Smart Monitor, among others, are the key players in the portable seizure monitoring devices market. Request a Sample Copy of the Report @ https://www.globalmarketestimates.com/market-report/portable-seizure-monitoring-devices-market-3766 Product Type Outlook (Revenue, USD Billion, 2022 - 2027) Bed Monitors, Video Monitors Android Devices Hospitals
BioSerenity Web Traffic
BioSerenity Rank
When was BioSerenity founded?
BioSerenity was founded in 2014.
Where is BioSerenity's headquarters?
BioSerenity's headquarters is located at Institut du Cerveau et de la Moelle Epinière, Paris.
What is BioSerenity's latest funding round?
BioSerenity's latest funding round is Series C.
How much did BioSerenity raise?
BioSerenity raised a total of $94.22M.
Who are BioSerenity's competitors?
Competitors of BioSerenity include Chronolife and 2 more.
You May Also Like
Hexoskin provides connected health devices and artificial intelligence for cardiorespiratory monitoring, physical activity, and sleep. Its customers include clinical research organizations, pharmaceutical companies, healthcare facilities, and defense & aerospace agencies.
VitalConnect currently markets the VitalConnect Platform that includes two wearable biosensors combined with mobile and cloud-based software and analytics. HealthPatch MD and VitalPatch biosensors are wireless, adhesive patches that continuously monitor and record single-lead ECG, heart rate, heart rate variability, respiratory rate, skin temperature, posture, step count, and fall detection with clinical accuracy. Through the VitalConnect Platform, care teams receive accurate data and notifications to make health decisions and enable timely interventions.
Equivital develops clinical-grade wearable technology used in a multitude of environments, including first response, health, safety, military, CBRN, and clinical research.
Dreem is a sleep health company focused on addressing insomnia. The company has created Dreem 2, a hardware/software solution that accurately tracks sleep activity, including brain activity, and provides digital coaching for behavior change and relaxation techniques driven by biofeedback.
Biofourmis discovers, develops, and delivers clinically-validated, software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, technology for pharmaceutical companies to demonstrate value, and cost-effective solutions for payers. Biofourmis has built Biovitals, a personalized, AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of its digital therapeutics product pipeline across multiple therapeutic areas, including heart failure, oncology, acute coronary syndrome, COPD, and chronic pain. The company was founded in 2015 and is based in Boston, Massachusetts.
myBrain Technologies creates digital therapy solutions with international reach. MBT develops a neurofeedback headset called the melomind solution. Clinical data demonstrates the effectiveness of brain training sessions in the management of stress and anxiety.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.